STARD13 and breast cancer: Looking at its level of expression by IHC we revealed that StarD13 is highly expressed in non-tumor in situ form of breast cancer and it is downregulated in grades I and II, suggesting the potential role of StarD13 as a tumor suppressor in breast cancer.